US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ALVR

AlloVir (ALVR)

AlloVir Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ALVR

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/18	09 : 00	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ALVR	AlloVir Inc
2024/05/14	05 : 00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ALVR	AlloVir Inc
2024/05/08	05 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALVR	AlloVir Inc
2024/03/14	19 : 10	PR Newswire (US)	Class Action Filed Against AlloVir, Inc. (ALVR) Seeking Recovery for Investors - Contact The Gross Law Firm	NASDAQ:ALVR	AlloVir Inc
2024/03/07	19 : 45	PR Newswire (US)	The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 19, 2024 in AlloVir, Inc. Lawsuit - ALVR	NASDAQ:ALVR	AlloVir Inc
2024/02/23	06 : 18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALVR	AlloVir Inc
2024/02/22	19 : 45	PR Newswire (US)	Class Action Filed Against AlloVir, Inc. (ALVR) Seeking Recovery for Investors - Contact The Gross Law Firm	NASDAQ:ALVR	AlloVir Inc
2024/02/22	10 : 22	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ALVR	AlloVir Inc
2024/02/21	07 : 00	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ALVR	AlloVir Inc
2024/02/16	06 : 30	Edgar (US Regulatory)	Form RW - Registration Withdrawal Request	NASDAQ:ALVR	AlloVir Inc
2024/02/13	06 : 34	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALVR	AlloVir Inc
2024/02/09	19 : 45	PR Newswire (US)	Shareholders that lost money on AlloVir, Inc.(ALVR) Urged to Join Class Action - Contact The Gross Law Firm to Learn More	NASDAQ:ALVR	AlloVir Inc
2024/02/07	06 : 38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALVR	AlloVir Inc
2024/02/06	10 : 00	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ALVR	AlloVir Inc
2024/02/02	19 : 45	PR Newswire (US)	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of AlloVir, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 19, 2024 - (NASDAQ: ALVR)	NASDAQ:ALVR	AlloVir Inc
2024/01/26	19 : 45	PR Newswire (US)	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of AlloVir, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 19, 2024 - (NASDAQ: ALVR)	NASDAQ:ALVR	AlloVir Inc
2024/01/26	06 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALVR	AlloVir Inc
2024/01/24	10 : 30	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ALVR	AlloVir Inc
2024/01/10	02 : 32	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:ALVR	AlloVir Inc
2024/01/10	02 : 29	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:ALVR	AlloVir Inc
2024/01/09	06 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALVR	AlloVir Inc
2024/01/05	20 : 14	IH Market News	Wall Street Highlights: Google Rejects Union Negotiations, Exxon Mobil Announces $2.5 Billion Accounting Write-Down in California	NASDAQ:ALVR	AlloVir Inc
2024/01/05	08 : 00	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ALVR	AlloVir Inc
2024/01/05	07 : 21	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALVR	AlloVir Inc
2023/12/22	21 : 07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALVR	AlloVir Inc
2023/12/22	21 : 00	GlobeNewswire Inc.	AlloVir Provides Updates on Phase 3 Clinical Development Program for Posoleucel, an Allogeneic Virus-Specific T Cell Therapy	NASDAQ:ALVR	AlloVir Inc
2023/11/22	07 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALVR	AlloVir Inc
2023/11/21	07 : 00	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ALVR	AlloVir Inc
2023/11/18	07 : 30	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ALVR	AlloVir Inc
2023/11/16	21 : 00	Business Wire	AlloVir to Present at the Piper Sandler 35th Annual Healthcare Conference	NASDAQ:ALVR	AlloVir Inc

Showing the most relevant articles for your search:NASDAQ:ALVR

1 2 3 4 5 6 7 8 9 10 次へ >>

Sierra Lake Acqusition

Skychain Technologies

Matthews Interna

Global Dividend Portfoli...

Goldman Sachs Bank Usa C...

Max Airlines 3x Leveraged

Morgan Stanley Bank Na C...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約